The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.
about
Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studiesPooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitisEfficacy of olopatadine versus epinastine for treating allergic conjunctivitis caused by Japanese cedar pollen: a double-blind randomized controlled trial.Recognition of allergic conjunctivitis in patients with allergic rhinitis.Emerging drugs for ocular allergy.Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.Olopatadine nasal spray for the treatment of seasonal allergic rhinitis in patients aged 6 years and older.Pharmacokinetic evaluation of olopatadine for the treatment of allergic rhinitis and conjunctivitis.Topical Olopatadine in the Treatment of Allergic Conjunctivitis: A Systematic Review and Meta-analysis.Double-masked, randomized, parallel-group study comparing olopatadine 0.1% ophthalmic solution with cromolyn sodium 2% and levocabastine 0.05% ophthalmic preparations in children with seasonal allergic conjunctivitis.Olopatadine nasal spray for the treatment of allergic rhinitis.Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops.Olopatadine ophthalmic solution suppresses substance P release in the conjunctivitis models.Pharmacology, clinical efficacy and safety of olopatadine hydrochloride.Cost-effectiveness of olopatadine in seasonal allergic conjunctivitis treatment.Interactions of olopatadine and selected antihistamines with model and natural membranes.Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by conjunctival allergen challenge.An assessment of the onset and duration of action of olopatadine nasal spray.Clinical implications of mast cell involvement in allergic conjunctivitis.Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis.
P2860
Q33565111-8F3983BD-74DC-4949-AB50-1DEC1058169DQ33803658-B1336BA7-9579-4AB6-BCE5-EF569F4BC5ABQ34402432-D5809AEE-6A17-4C9C-B207-8241623039FAQ34714641-3155C90C-CE46-4CA1-8248-574E6E88825BQ36219638-58D50929-5A5B-4FBC-96F5-FCDF688D1B03Q37716013-914CAADA-B684-485F-97BF-53649F705287Q37756143-687132F9-B3A5-4B86-929C-C23E4EFA82FEQ37950024-CB3A05C2-74F2-4E4C-A455-3555979D7812Q38837410-2972244E-7F2B-40E8-811E-921ACA16817BQ38922524-DC1F2CD8-6DD7-473F-9F21-B3C44D4A5BBDQ39287465-5C574F3A-1807-442B-9152-B208280885A5Q39956528-03B61C42-5C92-4C21-8802-ABC193DABCE9Q42138353-769FDB44-3106-4C01-A399-3EF205F9916AQ43061719-6B7052EE-4791-4416-8247-5AE452B1E2E6Q43266406-040C1763-B69A-42FF-A074-B02855C81CB3Q44713017-4C22BB1F-7AB0-4854-AA10-D11BD1E26679Q46846459-FD8BC263-48AF-42EC-8E37-1ECBD059C42CQ46883876-10E61D3A-8E31-4E79-A3BE-D49397D66394Q48361100-678F4128-2992-4E8C-A4F0-8D7ADDA7227CQ52764353-E32A50EA-7275-4772-BBA2-4DD354E34BCA
P2860
The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
The in vitro and in vivo ocula ...... allergic/antihistaminic agent.
@en
The in vitro and in vivo ocula ...... allergic/antihistaminic agent.
@nl
type
label
The in vitro and in vivo ocula ...... allergic/antihistaminic agent.
@en
The in vitro and in vivo ocula ...... allergic/antihistaminic agent.
@nl
prefLabel
The in vitro and in vivo ocula ...... allergic/antihistaminic agent.
@en
The in vitro and in vivo ocula ...... allergic/antihistaminic agent.
@nl
P2093
P356
P1476
The in vitro and in vivo ocula ...... allergic/antihistaminic agent.
@en
P2093
Gamache DA
Spellman JM
Stephens DJ
P304
P356
10.1089/JOP.1996.12.389
P577
1996-01-01T00:00:00Z